Bshra A. Alsfouk

1.2k total citations
76 papers, 970 citations indexed

About

Bshra A. Alsfouk is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Bshra A. Alsfouk has authored 76 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Organic Chemistry and 16 papers in Computational Theory and Mathematics. Recurrent topics in Bshra A. Alsfouk's work include Synthesis and biological activity (22 papers), Computational Drug Discovery Methods (16 papers) and Angiogenesis and VEGF in Cancer (15 papers). Bshra A. Alsfouk is often cited by papers focused on Synthesis and biological activity (22 papers), Computational Drug Discovery Methods (16 papers) and Angiogenesis and VEGF in Cancer (15 papers). Bshra A. Alsfouk collaborates with scholars based in Saudi Arabia, Egypt and United States. Bshra A. Alsfouk's co-authors include Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly, Hazem Elkady, Ibrahim M. Ibrahim, Dalal Z. Husein, Reda G. Yousef, Wagdy M. Eldehna, Mohammed S. Taghour and Zhibin Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Bshra A. Alsfouk

70 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bshra A. Alsfouk Saudi Arabia	19	468	443	180	170	161	76	970
Aisha A. Alsfouk Saudi Arabia	19	696 1.5×	662 1.5×	265 1.5×	189 1.1×	201 1.2×	92	1.3k
Mohamed M. Khalifa Egypt	23	537 1.1×	612 1.4×	118 0.7×	159 0.9×	150 0.9×	49	1.2k
Edgar S. Díaz‐Cruz United States	17	164 0.4×	356 0.8×	66 0.4×	80 0.5×	268 1.7×	30	1.1k
Haytham O. Tawfik Egypt	19	434 0.9×	329 0.7×	59 0.3×	49 0.3×	102 0.6×	56	694
Charles D. Thompson United States	18	164 0.4×	463 1.0×	89 0.5×	36 0.2×	203 1.3×	39	877
Mohamed O. Radwan Japan	19	421 0.9×	442 1.0×	51 0.3×	141 0.8×	122 0.8×	62	993
Mark A. Winter United States	13	197 0.4×	411 0.9×	168 0.9×	72 0.4×	694 4.3×	15	1.2k
Evgeny Kiselev United States	21	421 0.9×	928 2.1×	52 0.3×	135 0.8×	137 0.9×	40	1.3k
Christine M. Dieckhaus United States	12	171 0.4×	319 0.7×	54 0.3×	30 0.2×	90 0.6×	13	607
Abdelsattar M. Omar Saudi Arabia	19	522 1.1×	370 0.8×	93 0.5×	37 0.2×	64 0.4×	67	942

Countries citing papers authored by Bshra A. Alsfouk

Since Specialization

Citations

This map shows the geographic impact of Bshra A. Alsfouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bshra A. Alsfouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bshra A. Alsfouk more than expected).

Fields of papers citing papers by Bshra A. Alsfouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bshra A. Alsfouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bshra A. Alsfouk. The network helps show where Bshra A. Alsfouk may publish in the future.

Co-authorship network of co-authors of Bshra A. Alsfouk

This figure shows the co-authorship network connecting the top 25 collaborators of Bshra A. Alsfouk. A scholar is included among the top collaborators of Bshra A. Alsfouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bshra A. Alsfouk. Bshra A. Alsfouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elgammal, Walid E., Hazem Elkady, Reda G. Yousef, et al.. (2025). New nicotinamide–thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluation. RSC Advances. 15(18). 14477–14498. 4 indexed citations

Alsfouk, Bshra A., Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.. (2025). The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective. Brain Research Bulletin. 221. 111189–111189. 1 indexed citations

Meslamani, Ahmad Z. Al, et al.. (2025). Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial. Pharmaceuticals. 18(3). 412–412. 1 indexed citations

Gyebi, Gideon Ampoma, Matthew Iyobhebhe, Adebola Busola Ojo, et al.. (2025). Exploring the Multifunctional Agents of Flavonoid‐Rich Beet Leaf Extracts: Insights From Experimental and Computational Studies. 3(4). 723–739.

Elkady, Hazem, Walid E. Elgammal, Mohamed M. Khalifa, et al.. (2025). Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities. Archiv der Pharmazie. 358(7). e70042–e70042. 2 indexed citations

Alsfouk, Bshra A., et al.. (2025). Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen. Pharmaceuticals. 18(4). 539–539. 2 indexed citations

Eissa, Ibrahim H., Reda G. Yousef, Hazem Elkady, et al.. (2024). Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor. Journal of Chemistry. 2024. 1–25. 2 indexed citations

Abdel-Kader, Ahmed A., et al.. (2024). Comparative Efficacy of Inhaled and Intravenous Corticosteroids in Managing COVID-19-Related Acute Respiratory Distress Syndrome. Pharmaceutics. 16(7). 952–952. 1 indexed citations

El‐Metwally, Souad A., Hazem Elkady, Mohamed Hagras, et al.. (2023). Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-d]pyrimidines targeting VEGFR-2. RSC Advances. 13(33). 23365–23385. 15 indexed citations

10.

Alsfouk, Bshra A., et al.. (2023). Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30‐year cohort study. Epilepsia. 64(5). 1248–1258. 5 indexed citations

11.

Elgammal, Walid E., Hazem Elkady, Hazem A. Mahdy, et al.. (2023). Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies. RSC Advances. 13(51). 35853–35876. 20 indexed citations

12.

Elkady, Hazem, Alaa Elwan, Mohammed S. Taghour, et al.. (2023). Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors. RSC Advances. 13(40). 27801–27827. 16 indexed citations

13.

Taghour, Mohammed S., Hazem Elkady, Wagdy M. Eldehna, et al.. (2023). Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies. Journal of Biomolecular Structure and Dynamics. 41(21). 11535–11550. 41 indexed citations

14.

Mahdy, Hazem A., Hazem Elkady, Mohammed S. Taghour, et al.. (2023). New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations. Future Medicinal Chemistry. 15(14). 1233–1250. 24 indexed citations

15.

Elkaeed, Eslam B., Mohammed S. Taghour, Hazem A. Mahdy, et al.. (2022). New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2191–2205. 58 indexed citations

16.

Elkaeed, Eslam B., Mohamed M. Khalifa, Bshra A. Alsfouk, et al.. (2022). The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach. Metabolites. 12(11). 1122–1122. 10 indexed citations

17.

Taghour, Mohammed S., Hazem Elkady, Wagdy M. Eldehna, et al.. (2022). Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway. PLoS ONE. 17(9). e0272362–e0272362. 40 indexed citations

18.

Elkaeed, Eslam B., Reda G. Yousef, Mohamed M. Khalifa, et al.. (2022). Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies. Molecules. 27(19). 6203–6203. 33 indexed citations

19.

Yousef, Reda G., Wagdy M. Eldehna, Alaa Elwan, et al.. (2022). Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2. Molecules. 27(13). 4079–4079. 17 indexed citations

20.

Alsfouk, Bshra A., et al.. (2020). Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study. Epilepsia. 61(12). 2720–2728. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact